Phase 3 Primary Immunodeficiency Diseases Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Primary Immunodeficiency Diseases
Biopharma Plasma LLC56 enrolled12 locationsNCT07346859
Recruiting
Phase 3
A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases
Primary Immunodeficiency Diseases (PID)
Takeda39 enrolled5 locationsNCT06076642